- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
South San Francisco Today
By the People, for the People
Surrozen to Present at Upcoming Healthcare Investor Conference
Biotech company Surrozen will showcase its Wnt-based therapeutics pipeline at the Guggenheim Emerging Outlook: Biotech Summit 2026.
Published on Feb. 5, 2026
Got story updates? Submit your updates here. ›
Surrozen, Inc., a biotechnology company developing targeted therapeutics to harness the power of Wnt signaling for sight-threatening ophthalmic conditions, announced that the company's management will present at the upcoming Guggenheim Emerging Outlook: Biotech Summit 2026 on February 12, 2026.
Why it matters
Surrozen's presentation at the high-profile healthcare investor conference will provide an opportunity for the company to showcase its innovative Wnt-based therapeutic approach and pipeline to a wide audience of potential investors and industry partners as it seeks to advance its ocular disease treatments.
The details
Surrozen's presentation is scheduled for 1:30 PM Eastern Time / 10:30 AM Pacific Time on February 12, 2026. Interested parties will be able to access the live audio webcast via the Investors section of the Surrozen website. A replay of the webcast will also be archived on the company's website for at least 30 days.
- Surrozen will present at the Guggenheim Emerging Outlook: Biotech Summit 2026 on Thursday, February 12, 2026.
- The presentation is scheduled for 1:30 PM Eastern Time / 10:30 AM Pacific Time.
The players
Surrozen, Inc.
A biotechnology company pioneering targeted therapeutics to harness the power of Wnt signaling to address the underlying drivers of disease in sight-threatening ophthalmic conditions.
What’s next
Investors and interested parties will be able to access the live webcast of Surrozen's presentation and a replay will be available on the company's website.
The takeaway
Surrozen's presentation at the Guggenheim Emerging Outlook: Biotech Summit 2026 will provide an important platform for the company to showcase its innovative Wnt-based therapeutic approach and pipeline as it seeks to advance its ocular disease treatments and attract potential investors and partners.
